Mevalonate Promotes the Growth of Tumors Derived from Human Cancer Cells in Vivo and Stimulates Proliferation in Vitro with Enhanced Cyclin-dependent Kinase-2 Activity-Reference-Cited by-同舟云学术

Mevalonate Promotes the Growth of Tumors Derived from Human Cancer Cells in Vivo and Stimulates Proliferation in Vitro with Enhanced Cyclin-dependent Kinase-2 Activity

Published:2004-08 Issue:32 Volume:279 Page:33079-33084
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Duncan Robin E.,El-Sohemy Ahmed,Archer Michael C.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference65 articles.

1. Regulation of the mevalonate pathway

2. Essential role for mevalonate synthesis in DNA replication

3. Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins.

4. p21ras is modified by a farnesyl isoprenoid.

5. Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-ras mutations

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid traits and lipid-lowering drug target genes and risk of melanoma: a mendelian randomization study;Archives of Dermatological Research;2024-05-31

2. Harnessing Oxylipins and Inflammation Modulation for Prevention and Treatment of Colorectal Cancer;International Journal of Molecular Sciences;2024-05-15

3. Therapeutic influence of simvastatin on MCF-7 and MDA-MB-231 breast cancer cells via mitochondrial depletion and improvement in chemosensitivity of cytotoxic drugs;Advances in Cancer Biology - Metastasis;2023-12

4. Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways;Drugs in R&D;2023-10-17

5. Hypercholesterolemia Influences the Progression of Cancer by Changing the Biomolecular and Immunological Status of the Tumor Microenvironment;Handbook of Cancer and Immunology;2023